Skip to main content
Dr. Hoenle AG logo

Dr. Hoenle AG — Investor Relations & Filings

Ticker · HNL ISIN · DE0005157101 LEI · 529900C1AQEJPOAZ9I12 F Manufacturing
Open in API
Filings indexed 105 across all filing types
Latest filing 2026-03-26 Regulatory Filings
Country DE Germany
Listing F HNL

About Dr. Hoenle AG

https://www.hoenle.com/

Dr. Hoenle AG is a leading global supplier of industrial UV technology. The company develops, manufactures, and markets a comprehensive range of systems and equipment, including UV, LED-UV, IR, Inert-UV, and Excimer technologies, alongside high-tech industrial adhesives. Its portfolio also includes UV and IR lamps, UV measuring devices, reflectors, and electronic power supplies. Hoenle's solutions are applied in various industrial processes such as solvent-free radiation curing, drying, bonding, potting, fluorescence testing, and chemical-free disinfection of surfaces, liquids, and gases. Key markets include the printing, converting, and coating industries. The company specializes in providing customized systems for efficient and sustainable manufacturing.

Recent filings

Filing Released Lang Actions
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.10.2024 bis zum 30.09.2025
Regulatory Filings Classification · 55% confidence The document is a short statutory declaration (“Erklärung zur Einstandspflicht”) by the parent company under §264 HGB guaranteeing obligations of its subsidiaries. It is not a full annual or interim report, earnings release, call transcript, AGM materials, proxy statement, or any of the specific categories. It does not announce a report publication or dividend, nor is it a share issue or M&A notice. This falls under miscellaneous regulatory disclosures, making it a general Regulatory Filing (RNS).
2026-03-26 German
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.10.2024 bis zum 30.09.2025
Regulatory Filings Classification · 95% confidence The document is a formal declaration by Dr. Hönle AG regarding its liability for the obligations of its subsidiaries (uv-technik Speziallampen GmbH and Panacol-Elosol GmbH) pursuant to § 264 Abs. 3 HGB (German Commercial Code). This is a specific regulatory requirement for exemption from preparing individual financial statements for subsidiaries. Since it does not fit into financial reporting, M&A, or other specific categories, it is classified as a general regulatory filing.
2025-10-24 German
Hinweis auf Jahresfinanzbericht vom 01.10.2024 bis zum 30.09.2025
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) that explicitly states it is a 'Pre-announcement of a financial report' and provides a link to where the actual report will be available. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA) rather than the financial report itself.
2025-10-09 German
Hinweis auf Konzernabschluss vom 01.10.2024 bis zum 30.09.2025
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) announcing the upcoming disclosure and availability of the Hoenle AG group annual report for 2024/25. It provides a link to where the report will be available and specifies the publication date. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2025-10-09 German
Hinweis auf Jahresfinanzbericht vom 01.10.2024 bis zum 30.09.2025
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) announcing the upcoming disclosure and availability of a financial report (year report 2024/25). It provides a link to where the report will be available and specifies publication dates. Per the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2025-10-09 German
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.10.2024 bis zum 31.03.2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for Dr. Hönle Aktiengesellschaft, covering the period from 01.10.2024 to 31.03.2025. It contains detailed financial statements, segment reporting, management discussion and analysis (Konzernlagebericht), and balance sheet data. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. H1 2025
2025-05-08 German

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.